CRPC w/ Bone Metastases - Results from #120

A case report of image-based dosimetry of bone metastases with Alpharadin ((223)Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-up December 17, 2015

Continuous use of enzalutamide in a patient who developed enzalutamide-induced thrombocytopenia December 17, 2015

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial December 17, 2015

Health Economics and Radium-223 (Xofigo®) in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Case History and a Systematic Review of the Literature. November 24, 2015

[Vertebral metastases of urogenital carcinomas : Diagnosis and conservative therapy] October 20, 2015

Comparative efficacy, tolerability, and survival outcomes of various radiopharmaceuticals in castration-resistant prostate cancer with bone metastasis: a meta-analysis of randomized controlled trials October 19, 2015

Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (EAP) October 14, 2015

Management of bone metastases in prostate cancer: a review September 22, 2015

Stochastic simulation of radium-223 dichloride therapy at the sub-cellular level September 9, 2015

Multimodal Partial Volume Correction - Application to 18F-Fluoride PET/CT bone metastases studies September 4, 2015

Bayer Supports Prostate Cancer Awareness Efforts in Communities Nationwide throughout September September 3, 2015

Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer August 28, 2015

Radium-223 for the treatment of castration-resistant prostate cancer August 13, 2015

Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival August 13, 2015

Optimal sequence of bone target drugs in metastatic prostatic cancer August 12, 2015

Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational Study August 11, 2015

Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospects August 4, 2015

Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors July 26, 2015

The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer July 24, 2015

Radium-223 for the treatment of castration-resistant prostate cancer - Abstract July 3, 2015

Page 7 of 10

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.